International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e360-e364 , November 2009

Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting

  • N. Kumarasamy

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
    • Corresponding Author InformationCorresponding author. Tel.: +91 44 22542929; fax: +91 44 22542939.
  • ,
  • Kartik K. Venkatesh

      Affiliations

    • Brown University Medical School and the Miriam Hospital, Providence, Rhode Island, USA
  • ,
  • Bella Devaleenol

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Suneeta Saghayam

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Deepak Manohar

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • S. Poongulali

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Tokugha Yepthomi

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Pradeep Ambrose

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Suniti Solomon

      Affiliations

    • YRG Centre for AIDS Research and Education, Voluntary Health Services, Taramani, Chennai 600113, India
  • ,
  • Kenneth H. Mayer

      Affiliations

    • Brown University Medical School and the Miriam Hospital, Providence, Rhode Island, USA

Received 31 May 2008 ,Revised 24 October 2008 ,Accepted 17 November 2008.

References 

  1. World Health Organization. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach (2006 revision). Available at: www.who.int/hiv/pub/guidelines/adult/en/index.html (accessed January 2009).
  2. Department of Health and Human Services. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://aidsinfo.nih.gov/Guidelines/GuidelineDetail.aspx?MenuItem=Guidelines&Search=Off&GuidelineID=7&ClassID=1 (accessed January 2009).
  3. Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, et al. Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006;41:53–58
  4. Huffam S, Srasuebkul P, Zhou J, Calmy A, Saphonn V, Kaldor JM, et al. on behalf of the TREAT Asia HIV Observational Database (TAHOD) Prior antiretroviral therapy experience protects against zidovudine-related anaemia. HIV Med. 2007;8:465–471
  5. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, et al. Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS. 2008;22:337–344
  6. Curkendall S, Richardson JT, Emons MF, Fisher AE, Everhard F. Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy. HIV Med. 2007;8:483–490
  7. Rogers M, Gopalakrishnan G, Kumarasamy N, Flanigan TP, Carpenter CC, Mayer KH, et al. HIV in couples in South India: implications for prevention. Int J STD AIDS. 2005;16:442–445
  8. World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents, and adults in resource-limited settings: recommendations for a public health approach. Available at: http://www.who.int/hiv/pub/guidelines/ctx/en/index.html (accessed January 2009).
  9. Benson C, Kaplan JE, Masur H, Pau A, Holmes KK. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. University of Colorado Health Sciences Center; Centers for Disease Control and Prevention; National Institutes of Health; University of Washington; 2005.
  10. Semba R, Shah N, Klein RS, Mayer KH, Schuman P, Vlahov D Human Immunodeficiency Virus Epidemiology Research Study Group. Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis. 2002;34:260–266
  11. Semba R, Shah N, Klein RS, Mayer KH, Schuman P, Gardner LI, et al. HER (Human Immunodeficiency Virus Epidemiology Research) Study Gr*oup Highly active antiretroviral therapy associated with improved anemia among HIV-infected women. AIDS Patient Care STDS. 2001;15:473–480
  12. O’Brien M, Kupka R, Msamanga GI, Saathoff E, Hunter DJ, Fawzi WW. Anemia is an independent predictor of mortality and immunologic progression of disease among women with HIV in Tanzania. J Acquir Immune Defic Syndr. 2005;40:219–225
  13. Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003;36:79–85
  14. Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP, et al. The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis. 2005;41:1525–1528
  15. Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenol B, Saghayam S, Yepthomi T, et al. Gender-based differences in treatment and outcome among HIV patients in South India. J Womens Health (Larchmt). 2008;17:1471–1475
  16. Belperio P, Rhew DC. Prevalence and outcomes of anemia in individuals with human immunodeficiency virus: a systematic review of the literature. Am J Med. 2004;116:S27–43

PII: S1201-9712(09)00072-1

doi: 10.1016/j.ijid.2008.11.030

International Journal of Infectious Diseases
Volume 13, Issue 6 , Pages e360-e364 , November 2009